MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Avadel Pharmaceuticals plc ROCE 2011-2026 | AVDL
ROCE Jährlich Avadel Pharmaceuticals plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -57.41 | -157.11 | 466.12 | -109.33 | -12.36 | -14.57 | -39.86 | 36.59 | 24.21 | 61.62 | -32.27 | -28.95 | -19.45 | -18.76 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 466.12 | -157.11 | 7.03 |
ROCE Vierteljährlich Avadel Pharmaceuticals plc
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 136.33 | 272.67 | 1171.14 | 982.98 | 957.04 | 794.77 | -122.15 | -55.24 | -63.68 | -46.18 | -2.92 | 12.37 | 26.57 | 49.22 | 39.64 | 57.42 | -449.6 | -970.81 | -1086.24 | -1061.33 | -1030.81 | -493.28 | -353.22 | 109.35 | 70.87 | 1.87 | -65.45 | -52.36 | -73.32 | -55.79 | -29.6 | -15.59 | -30.01 | -23.47 | -36.4 | -45.37 | -53.58 | -47.36 | -67.11 | -42.13 | -42.13 | -39.32 | -10.78 | -10.82 | -5.43 | -5.43 | -0.04 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1171.14 | -1086.24 | -38.4 |
ROCE anderer Aktien in der Arzneimittelhersteller
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M |  USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Canopy Growth Corporation
CGC
|
-24.04 | - | -3.21 % | $ 114 M |  Canada |
 |
Cronos Group
CRON
|
-10.43 | - | -1.32 % | $ 1.35 B | Canada |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | - | 1.17 % | $ 55 M | USA |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 11.07 | - | $ 567 M | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Evolus
EOLS
|
-623.16 | $ 4.35 | - | $ 270 M | USA |
 |
China Pharma Holdings
CPHI
|
-59.23 | - | -2.39 % | $ 11.4 M |  China |
 |
Harrow Health
HROW
|
0.61 | $ 49.44 | 3.63 % | $ 1.61 B | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 21.69 | 2.05 % | $ 1 B | USA |
 |
Perrigo Company plc
PRGO
|
1.31 | $ 14.49 | 0.59 % | $ 1.99 B | USA |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.33 | - | $ 402 M | Canada |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Bausch Health Companies
BHC
|
-94.23 | - | - | $ 2.22 B | Canada |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.51 | 1.01 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 7.54 | - | $ 4.66 B | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-29.88 | - | - | $ 193 M | Canada |
 |
Organogenesis Holdings
ORGO
|
-0.49 | - | -2.73 % | $ 492 M | USA |
 |
cbdMD
YCBD
|
-235.96 | $ 0.75 | -6.86 % | $ 3.23 M | USA |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Aurora Cannabis
ACB
|
-23.09 | - | -3.23 % | $ 86.3 M | Canada |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
Rockwell Medical
RMTI
|
-31.33 | $ 1.08 | -1.38 % | $ 25.2 M | USA |
 |
Relmada Therapeutics
RLMD
|
-121.49 | - | - | $ 120 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
-176.47 | - | 2.31 % | $ 849 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
-84.11 | - | - | $ 3.52 M | USA |
 |
Solid Biosciences
SLDB
|
-81.9 | - | - | $ 261 M | USA |
 |
SCYNEXIS
SCYX
|
99.6 | $ 0.81 | - | $ 38.8 M | USA |
 |
Veru
VERU
|
-114.23 | - | 3.03 % | $ 321 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
TherapeuticsMD
TXMD
|
-29.1 | $ 2.32 | -2.52 % | $ 24.2 M | USA |
 |
Viatris
VTRS
|
7.66 | - | - | $ 19.4 B | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-190.63 | - | 7.5 % | $ 6.35 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |